Healy BC, Glanz BI, Zurawski JD, Mazzola M, Chitnis T, Weiner HL. Long-term follow-up for multiple sclerosis patients initially treated with interferon-beta, glatiramer acetate. J Neurol Sci. 2018, 394:127-131. doi: 10.1016/j.jns.2018.09.020.
Advertisement
Articles by Healy BC, Glanz BI, Zurawski JD, Mazzola M, Chitnis T, Weiner HL. Long-term follow-up for multiple sclerosis patients initially treated with interferon-beta, glatiramer acetate. J Neurol Sci. 2018, 394:127-131. doi: 10.1016/j.jns.2018.09.020.
Advertisement
Latest Updated Articles
- Interferon-beta Versus Glatiramer Acetate as Initial Treatment for Multiple Sclerosis: Long-term Follow-up
Published: January 19th 2019 | Updated:
Advertisement
Advertisement
Trending on AJMC
1
RSV Vaccination Effective in Older Adults, but Protection Declines Over Time
2
Barriers to Treatment in Pediatric Myasthenia Gravis: Jonathan Strober, MD
3
Defining Relapse and Switching Therapies in Multiple Myeloma
4
Tapinarof Shows Strong Efficacy, Sleep Benefits in Pediatric AD Across Comorbidities: Druhan Howell, MD
5
